Affordable Jardiance for Diabetes Treatment

Your Guide to Affordable Jardiance® (Empagliflozin) Access For Diabetes Treatment with MedsPartner

Summary - This blog provides the latest updates as of September 2025 on the use of Jardiance® for diabetes management, along with practical options to access it at more affordable prices when the branded medication is costly.

Dealing with diabetes is not just about lifestyle changes and regular monitoring -  it’s also about having access to the right medications at budget-friendly prices. One of the most commonly prescribed drugs for Diabetes is Jardiance® (empagliflozin). It helps lower blood sugar in adults with type 2 diabetes and reduces the risk of heart failure in certain patients.

The challenge, though? In countries like the USA, UK, and Australia, Jardiance® can cost hundreds of dollars each month, putting it out of reach for many patients, leaving them overwhelmed.

In this blog, we break down everything you need to know about Jardiance®, from its generics to safe and affordable access.

What is Jardiance® used for?

If you are dealing with type 2 diabetes, you may have been prescribed Jardiance® as it helps to control blood sugar. It is also given to patients with heart failure or kidney problems, as it helps reduce the risk of serious complications in such cases.

Why is Jardiance® expensive?

Jardiance® costs remain high as it’s still under patent protection, and the alternatives are not yet available in the USA, UK, and many other countries. The brand manufacturer often holds exclusive rights, allowing them to set higher prices to recover research, development, and clinical trial costs while generating profit. Once the patent expires and generics enter the market, prices are expected to fall.

The latest news around the cost of Jardiance®

1. Maryland’s Prescription Drug Affordability Board (PDAB) has declared Jardiance®  (Boehringer Ingelheim/Eli Lilly) and Farxiga (AstraZeneca) unaffordable. These drugs, could soon face upper payment limits for state and local government programs, potentially saving millions in taxpayer dollars.

What this means for patients - since generics are not yet available in the U.S., retail prices will remain high. The ruling may lower costs for those on state health plans or Medicaid, but most patients won’t see immediate savings. Instead, the move pressures manufacturers to offer deeper discounts or expand assistance programs, until generics arrive later this decade.

2. Scripius, the PBM of Intermountain Health, has dropped Jardiance®  from its preferred formulary, replacing it with Brenzavvy®  while keeping Farxiga®  as preferred, anticipating its generic entry in 2026. 

What this means for patients - this could mean higher costs or prior authorizations if they want to stay on Jardiance® , and many may be steered toward Brenzavvy®  or Farxiga® . While the change aims to cut systemwide costs, it may force stable Jardiance®  users to switch therapies unless exceptions are approved.

How can patients deal with the high price of Jardiance®?

While generic Jardiance® is approved and available in a few countries, including India, many regions, like the US, UK, Australia, and much of Europe, do not have local access to generics due to ongoing patent protections and regulatory exclusivities. In these regions, patients are often limited to the expensive branded version. This makes trusted personal importation one of the few viable pathways for accessing affordable diabetes treatment.

Are there other ways to get Jardiance® for cheaper?

Government schemes like Medicare (USA), NHS (UK), PBS (Australia) and Pharmac (NZ) offer cost relief on Jardiance® , if it is prescribed for eligible uses.

For patients struggling with Jardiance® costs, affordable access is possible through manufacturer assistance programs, copay cards, and patient support initiatives. Boehringer Ingelheim and Eli Lilly, who co-market Jardiance®  in the U.S., offer a Savings Card that can reduce copays for eligible insured patients. 

Uninsured or underinsured patients may get free meds through Boehringer Ingelheim Cares Foundation Patient Assistance Program if they qualify. Nonprofit orgs can also help, though access varies by insurance type, state, and patient eligibility.

However, these programs may not exist in all countries, and where they do exist, many patients may still not be eligible. For those patients, personal importation of affordable generic versions of Jardiance® is a suitable option, through credible sources like MedsPartner.

Case Study: Accessing Jardiance with MedsPartner

Mr. R., a 62-year-old living in Melbourne, was prescribed Jardiance to help manage his type 2 diabetes. Despite his doctor’s recommendation, the out-of-pocket costs in Australia made it difficult for him to continue long-term therapy, as he did not qualify for the subsidized PBS price due to certain eligibility criteria. After discovering MedsPartner through an online patient forum and going through excellent customer reviews on Trustpilot, he connected with our team, who guided him through the importation process. Within a few weeks, he was able to access authentic Jardiance at a fraction of the local price.

Since then, Mr. R. has continued his treatment without interruption. His follow-up reports show improved blood sugar control and overall well-being, giving him the confidence to manage his condition without financial stress.

When will Jardiance® go generic?

Generic entry is expected in the US around 2034. But generic equivalents of Jardiance® are now available in some markets like India, and they are bioequivalent to the branded version. That means that when compared to the brand medicine, the generic version has a similar:

  • Active ingredient
  • Strength and dosage
  • Safety profile
  • Effectiveness

All of this is at a fraction of the cost and easily accessible!

This table shows the huge price difference between branded and generic Jardiance®. It also shows how the generics in India sourced through MedsPartner are way more affordable!


Country


Branded Jardiance® price



Generic Empagliflozin price


Price via MedsPartner for 30 tablets of 10mg

USA

~USD 620 for 30 tabs 10 mg

Generic not available

USD 40.00

Is it legal to import generic empagliflozin from India?

Yes, personal importation of generic Empagliflozin is legal in many countries. Most countries allow patients to import prescription medications for personal use in limited quantities with a valid prescription and supporting documents.

MedsPartner helps you source the medicine as per your local laws and supports customers with compliant documentation throughout the process.

Jardiance® - Where to buy?

You can purchase Jardiance® from local pharmacies in your country. Check for any financial support programs that may help you get the medicine at a discounted price. You can also buy affordable Jardiance® alternatives from MedsPartner via personal import.

How Does MedsPartner Help Patients Get Access to Jardiance® Easily and Affordably? Can I trust the quality?

At MedsPartner, we aim to be the bridge between patients and life-changing treatments. We source authentic and high-quality generic Empagliflozin from licensed manufacturers that are approved by global regulatory bodies such as the EMA or FDA.

We offer

  • Genuine Empagliflozin generics from reputed licensed manufacturers.
  • Legal and quick delivery for personal use across 40+ countries.
  • Full prescription assistance and documentation process.
  • Transparent sourcing with no hidden info or costs.

Answering Your FAQs About Jardiance®

1. Which is better, Jardiance® or Farxiga®?

Farxiga® and Jardiance® are similar medications - both are effective for their FDA-approved uses. Through MedsPartner’s personal import service, patients can legally and safely access high-quality, affordable versions when local prices are too high.

2. Who sells Jardiance®?

Jardiance® is sold by local pharmacies, hospitals, and authorized distributors in many countries. When prices are high or supply is limited, patients can use personal import through MedsPartner. We help patients import authentic, high-quality Jardiance® affordably and legally.

3. Is there a generic for Jardiance®?

Yes, Empagliflozin is the generic for Jardiance®. It has the same active ingredient as the branded med with similar therapeutic benefits. Affordable Empagliflozin is available via personal importation through MedsPartner.

4. What does Jardiance® do?

Jardiance®  treats type 2 diabetes. It works by helping the kidneys remove glucose from the blood through urine, thereby decreasing the blood sugar levels.

5. Are Jardiance® and empagliflozin the same thing?

Yes! Jardiance® is the brand name, while empagliflozin is the same active ingredient - also available as a generic. With MedsPartner, patients can legally access authentic and high-quality empagliflozin through personal import at a much more affordable price globally.

6. What does compliant personal importation of Jardiance mean, and how does it help patients?

Compliant personal importation means that when you order Jardiance through MedsPartner, every step follows your country’s legal and safety requirements. Patients must provide a valid prescription from their doctor, and medicines are only dispatched after verification and approval by licensed pharmacists. Each shipment is tracked end-to-end, with the necessary documents prepared to ensure smooth customs clearance.

This process protects patients in two ways: it guarantees that the medicine you receive is authentic and safe, and it also ensures that you stay fully compliant with local regulations—making access to Jardiance both secure and stress-free.

Affordable Jardiance® Access Is Now a Reality with MedsPartner.

The introduction of Empagliflozin generics is a turning point in Diabetes treatment. For those facing cost hurdles with branded meds, MedsPartner provides a safe, high-quality and affordable alternatives through trusted personal importation. 

Visit medspartner.com or drop an email on support@medspartner.com for free support with prescriptions, import rules, and shipping to your country.

About the Author - Aayyush Goyal has a background in healthcare consulting and pharmaceutical supply chains, with over a decade of experience in drug pricing, regulatory policy, and patient rights. Aayyush is a recognized advocate for ethical sourcing, generic access, and cross-border care solutions.

 

Back to blog